Oak Associates’s Eli Lilly LLY Stock Holding History

Oak Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Hold	1,170	–	–	0.08%	86
2026 Q1	$1.08M	Hold	1,170	–	–	0.07%	92
2025 Q4	$1.26M	Sell	1,170 -24	-2%	-$22.9K	0.08%	92
2025 Q3	$911K	Buy	+1,194	New	+$889K	0.06%	97
2023 Q1	–	Sell	-5,740	Closed	-$2.1M	–	142
2022 Q4	$2.1M	Buy	+5,740	New	+$2.04M	0.18%	85
2017 Q4	–	Sell	-22,500	Closed	-$1.93M	–	160
2017 Q3	$1.93M	Hold	22,500	–	–	0.14%	95
2017 Q2	$1.85M	Hold	22,500	–	–	0.14%	99
2017 Q1	$1.89M	Hold	22,500	–	–	0.15%	100
2016 Q4	$1.66M	Hold	22,500	–	–	0.16%	99
2016 Q3	$1.66M	Hold	22,500	–	–	0.17%	101
2016 Q2	$1.77M	Sell	22,500 -3,200	-12%	-$241K	0.21%	97
2016 Q1	$1.85M	Sell	25,700 -1,800	-7%	-$136K	0.23%	89
2015 Q4	$2.32M	Hold	27,500	–	–	0.28%	79
2015 Q3	$2.3M	Sell	27,500 -500	-2%	-$42.2K	0.31%	76
2015 Q2	$2.34M	Sell	28,000 -1,400	-5%	-$107K	0.28%	81
2015 Q1	$2.14M	Sell	29,400 -1,500	-5%	-$107K	0.26%	88
2014 Q4	$2.13M	Sell	30,900 -500	-2%	-$33.8K	0.26%	87
2014 Q3	$2.04M	Hold	31,400	–	–	0.25%	83
2014 Q2	$1.95M	Sell	31,400 -1,500	-5%	-$89.5K	0.24%	88
2014 Q1	$1.94M	Hold	32,900	–	–	0.24%	87
2013 Q4	$1.68M	Buy	+32,900	New	+$1.65M	0.18%	94
2013 Q2	$1.62M	Buy	+32,900	New	+$1.79M	0.19%	87

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oak Associates's LLY Position: Q2 2026 in Review

Oak Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 1,170 shares worth $1.4M. The position accounts for 0.08% of the portfolio, ranked #86.

Oak Associates first reported a position in LLY in Q2 2013 and has held it in 22 quarters since. The position peaked at $2.34M in Q2 2015. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Oak Associates held 1,170 shares of Eli Lilly worth $1.4M as of Q2 2026.
Oak Associates left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.08% of Oak Associates's portfolio in Q2 2026, its #86 holding.
Oak Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 22 quarters since.
Oak Associates's Eli Lilly position peaked at $2.34M in Q2 2015.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oak Associates's 13F filing for Q2 2026, filed 14 Aug 2026.